IBN
Închide

Lista articolelor în limba engleza

Print PDF
Afisarea articolelor: 1-5(5)
2023
1.

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

. The Lancet Infectious Diseases. 2023, nr. , 0-0. ISSN 1473-3099 ISSNe 1474-4457. (Cat. )
2.

Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project

. The Lancet Infectious Diseases. 2023, nr. , 0-0. ISSN 1473-3099 ISSNe 1474-4457. (Cat. )
2022
3.

Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study

. The Lancet Infectious Diseases. 2022, nr. , 249-242. ISSN 1473-3099 ISSNe 1474-4457. (Cat. )
2020
4.

Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services

. The Lancet Infectious Diseases. 2020, nr. , 53-47. ISSN 1473-3099 ISSNe 1474-4457. (Cat. )
2014
5.

Antibiotic use in eastern Europe: A cross-national database study in coordination with the WHO Regional Office for Europe

. The Lancet Infectious Diseases. 2014, nr. , 387-381. ISSN 1473-3099 ISSNe 1474-4457. (Cat. )
 
 

1-5 of 5